MedTrace Logo

Mirror Therapy for Impingement Syndrome

NCT05188157 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 62

Last updated 2022-06-01

No results posted yet for this study

Summary

Background: Mirror therapy is an adjuvant treatment option based on shoulder impingement Syndrome Objective:To investigate the effect of mirror theraphy on shoulder impingement Syndrome Methods: The study included 62 participants, including cases in the intervention group (IG) (± years) and 20 cases in the control group (CG) (years) who met the selection criteria. IG received mirror theraphy with regular physiotherapy while CG received only regular physiotherapy. The patients were evaluated with the before treatment, immediately after treatment (post-treatment).

Conditions

  • Impingement Syndrome
  • Mirror Movements 2

Interventions

OTHER

mirror therapy

The patients in IG will receive exercise program before mirror theraphy. The patient will continue to do the exercises in front of the mirror for the remaining 20 minutes of the exercise. While doing the exercise with the healthy side in front of the mirror, the patient will try to do the same movement with the shoulder diagnosed with impingement syndrome on the other side of the mirror. The patient will try to do the movement correctly with the reflection in the mirror.

OTHER

conventional physiotherapy

The conventional physiotherapy program included, wand exercises for shoulder abduction, flexion, hyperextension and internal and external rotation, Codman exercises and isometric and resistive exercises of the shoulder girdle. The exercise program is performed under the supervision of an experienced physiotherapist. The isometric exercises will be used during the painful period, and the resistance exercises will be added after the pain began to relieve.under the supervision of a physician in the first 30 minutes of their exercise.

Sponsors & Collaborators

  • Kutahya Health Sciences University

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-14
Primary Completion
2022-02-15
Completion
2022-03-01

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05188157 on ClinicalTrials.gov